Results 41 to 50 of about 183,150 (159)

Injection of α-syn-98 Aggregates Into the Brain Triggers α-Synuclein Pathology and an Inflammatory Response

open access: yesFrontiers in Molecular Neuroscience, 2019
Pathological aggregation of α-synuclein (α-syn) is a major component of Lewy bodies (LB), which play a central role in pathogenesis of Parkinson’s disease (PD). Differential expression of α-syn isoforms has been shown in PD. Isoform α-syn-98 is generated
Tingfu Du   +11 more
doaj   +1 more source

Vaccine Safety

open access: yes, 2017
“Are vaccines safe?” has become one of the most hotly contested and politically charged questions in contemporary culture, fueled in no small part by voracious online debates, peer-to-peer influence, and source information of varying degrees of quality and accuracy.
C. John Clements   +2 more
openaire   +2 more sources

Repeated-dose toxicity and immunogenicity evaluation of norovirus P particle-based rotavirus vaccine in juvenile cynomolgus monkeys

open access: yesFrontiers in Immunology
IntroductionRotavirus remains a major cause of mortality among young children worldwide, underscoring the urgent need for new vaccines. The present study evaluated the repeated-dose toxicity and immunogenicity of a bivalent rotavirus subunit candidate ...
Wei Pan   +36 more
doaj   +1 more source

Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group

open access: yesBMJ Global Health
This analysis describes the successes, challenges and opportunities to improve global vaccine safety surveillance as observed by the Vaccine Safety Working Group from its role as a platform of exchange for stakeholders responsible for monitoring the ...
Rebecca E Chandler   +12 more
doaj   +1 more source

Enhanced passive safety surveillance of standard-dose and high-dose influenza vaccines in Finland and Germany 2023–24 season

open access: yesHuman Vaccines & Immunotherapeutics
Enhanced Passive Safety Surveillance was used to detect safety signals before the peak period of immunization with quadrivalent inactivated influenza vaccines (IIV4) in Finland (standard dose [SD]) and Germany (high dose [HD]) in the 2023–24 season.
Marina Amaral de Avila Machado   +7 more
doaj   +1 more source

Communicating COVID-19 Vaccine Safety: Knowledge and Attitude Among Residents of South East, Nigeria

open access: yesInfection and Drug Resistance, 2021
Luke Ifeanyi Anorue, Alphonsus Chukwuma Ugwu, Stanley Uzoamaka Ugboaja, Uzoma O Nwabunze, Chinyere Christiana Ugwulor-Onyinyechi, Chioma Njoku Department of Mass Communication, University of Nigeria, Nsukka, NigeriaCorrespondence: Chioma NjokuDepartment ...
Anorue LI   +5 more
doaj  

Vaccine Safety International Monitoring

open access: yesБезопасность и риск фармакотерапии, 2019
Vaccine safety is an important aspect of mass immunization of the population. Adverse reactions that occur following vaccination result in a decrease in public confidence. The aim of this research was to identify information on the development of adverse
M. A. Darmostukova   +4 more
doaj   +1 more source

Editorial: Immunological aspects of vaccine safety

open access: yesFrontiers in Immunology, 2023
Michael Vajdy   +2 more
doaj   +1 more source

Strategies for identifying and using diverse global health data: perspectives from data searching and meta-analyses on antimicrobial resistance

open access: yesDiscover Public Health
Searching for and utilizing biomedical data is an essential part of most research efforts, including in public health, and almost always involves use of major online databases.
Danielle M. Venne   +6 more
doaj   +1 more source

Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2

open access: yesnpj Vaccines
The COVID-19 pandemic spurred mRNA vaccine innovation, but new SARS-CoV-2 variants highlight the need for vaccines with improved potency and durability.
Jason P. Laliberte   +28 more
doaj   +1 more source

Home - About - Disclaimer - Privacy